20/20 HealthCare Partners LLC
Venture capitalAuburndale · Seed–Late Stage · 7 people tracked
Find your way into 20/20 HealthCare Partners LLC
13 people in our graph share verified history with the 20/20 HealthCare Partners LLC team — schools, employers, funds. One of them is your warm intro.
Investment thesis
20/20 HCP invests at the early stage of life sciences and healthcare technology, targeting companies in diagnostic imaging, medical devices, healthcare IT, biotechnology and pharmaceuticals. It focuses on the phase after proof of concept has been established, funding program development through to the completion of verification and validation studies (pre-regulatory approval and pre-commercialization). It typically acts as lead investor providing managerial and operational support alongside capital, aiming for short investment periods of about 2-3 years to exit and returns in the 3-7x range, with exit routes including sale, licensing, partnership with big pharma, or a follow-on financing round.
Source: firm website, verified Aug 3, 2026.
Team · 7 people
from the firm's website & public directories
What they invest in
from 7 of 17 portfolio companiesHealthtech ×6Biotech ×4AI & Machine Learning ×2Digital Health ×2Medical Devices ×2Cloud Computing ×1Enterprise Software ×1Media & Entertainment ×1
HQs:United States×6
Investments · 17 tracked
founders shown can be your intro pathBy year:2024 · 12021 · 12017 · 13 dated
Variantyx is a molecular diagnostics company offering genetic testing for rare genetic disorders, reproductive genetics, and precision oncology.
AI & Machine LearningBiotechDigital HealthHealthtechFramingham, US
Haim Neerman(Co-founder)inTomer Jackman(Co-founder & VP Customer Support and Lab Services)inJeffrey Weisberg(Chief Financial Officer)inYaron Rachmany(Operations, R&D, IT (executive))inChristine Stanley(Chief Genomics and Compliance Officer)inEyal Reinstein(Chief Medical Officer)in
Co-investorsBosch VenturesNew Era Capital PartnersOrbiMedPeregrine VenturesPitangoQuark Venture Inc.+2 more
Portable, connected precision-medicine platform for coagulation management.
PartnerHillel Bachrach· solo GP
HealthtechWaltham, US
Stephen J. Lemaster(Executive Officer)Mark J. Toland(Executive Officer, Director)David W. Long(Executive Officer)David M Handler(Executive Officer, Director)
BoardJeffrey C. Lightcap(Director)Louis A. Cannon(Director)
PartnerHillel Bachrach· led
Co-investorsBioStar Ventures
Developing device-based therapies to treat neurodegenerative diseases such as ALS and PSP.
PartnerHillel Bachrach· solo GP
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)
PartnerHillel Bachrach· led
Co-investorsFlucas VenturesTachyon VenturesVU Venture PartnersDolby Family Ventures
AI imaging platform for oncology care that tracks patient journeys and analyzes disease progression.
PartnerHillel Bachrach· solo GP
Medical diagnostic platform analyzing protein function for neurodegenerative disease and oncology, including a blood-based ALS diagnostic.
PartnerHillel Bachrach· solo GP
HealthtechNaperville, US
Matthew Pipke(Executive Officer, Director, Promoter)Gary Conkright(Executive Officer, Director, Promoter)
BoardRobert Lynch(Director)Edward Michael(Director)David Ormesher(Director)
PartnerHillel Bachrach· solo GP
Co-investors4490 Ventures
UK IP development company creating medical diagnostic technologies analyzing protein/nucleic acid interactions.
PartnerHillel Bachrach· solo GP
Remedy Plan is a biopharmaceutical company developing drugs that target NAMPT, an essential enzyme dysregulated in more than 20 diseases including cancer.
BiotechHealthtechRockville, US
Gregory Plan Crimmins(Executive Officer, Director)
PartnerHillel Bachrach· solo GP
Co-investorsSchooner CapitalAlexandria
Biotech delivery company named a Fierce 15 biotech company.
PartnerHillel Bachrach· solo GP
Provider of dose and procedure-time reduction software for nuclear medicine; sold to Pharmalogic in 2019.
PartnerHillel Bachrach· solo GP
Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.
AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US
Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in
PartnerHillel Bachrach· led
Co-investorsHighlight Capital
Provider of digital radiography hardware and software solutions; acquired by Konica Minolta in 2015.
PartnerHillel Bachrach· solo GP
XR therapeutics platform company that merged with Amelia Virtual Care.
PartnerHillel Bachrach· solo GP
Co-investorsAsabys PartnersBridges IsraelFlying Tiger Capital
Zixi provides software solutions for broadcast and live video workflows, serving content owners, broadcasters, service providers, sports organizations, and OTT providers with capabilities for content contribution, satellite replacement, B2B distribution, and direct-to-consumer enablement.
Cloud ComputingEnterprise SoftwareMedia & EntertainmentSaaS
Uri Avni(Co-Founder, CTO)
PartnerHillel Bachrach· led
Co-investorsSchooner Capital
Exits · 2
IPOs and acquisitions across the tracked portfolioViztekacq. by Konica MinoltaZixiacq. by Clearhaven Partners
Portfolio news
latest coverage across their companiesRemedy Plan · trial.medpath.com · May 17, 2025
Frequently asked questions
- How many investments has 20/20 HealthCare Partners LLC made?
- 20/20 HealthCare Partners LLC has 17 tracked investments, 2 of which have exited via acquisition or IPO.
- What stage does 20/20 HealthCare Partners LLC invest at?
- 20/20 HealthCare Partners LLC invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does 20/20 HealthCare Partners LLC focus on?
- 20/20 HealthCare Partners LLC focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Media & Entertainment, Medical Devices.
- Where is 20/20 HealthCare Partners LLC located?
- 20/20 HealthCare Partners LLC is headquartered in Auburndale, US.
- Does 20/20 HealthCare Partners LLC lead rounds?
- Yes, 20/20 HealthCare Partners LLC leads investment rounds.
- Who does 20/20 HealthCare Partners LLC co-invest with?
- 20/20 HealthCare Partners LLC most often shares deals with Schooner Capital, Bosch Ventures, OrbiMed, among 12 tracked co-investors.
Images
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Olive Tree Capital invests in technology and life sciences companies, backing entrepreneurs across healthcare, fintech, enterprise, AI/ML, and frontier technology sectors.